Genelux (GNLX) Selling, General & Administrative (2022 - 2026)
Genelux (GNLX) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - | 2.17 Mn |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn | 555.10 Mn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn | 493.70 Mn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn | 647.70 Mn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - | 17.02 Mn |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn | 1.13 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn | 322.55 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - | 101.25 Mn |
| 10 | Genelux | 128.04 Mn | 128.04 Mn | - | 3.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.39 Mn |
| Dec 31, 2025 | 3.77 Mn |
| Sep 30, 2025 | 3.45 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 3.23 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 4.11 Mn |
| Dec 31, 2023 | 2.84 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 2.45 Mn |
| Mar 31, 2023 | 3.79 Mn |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 2.24 Mn |